Clicky

mobile btn
Tuesday, February 10th, 2026

Emerging Infectious Diseases

NIAID Ebola study shows promise in ZMapp treatment

According to a recent clinical trial conducted by the National Institute of Allergy and Infectious Diseases (NIAID), ZMapp was found to be a safe and effective treatment for Ebola virus disease, but more study remains. The trial, known as Partnership for Research on Ebola Virus in Liberia... Read More »

CDC awards $2.4 million to five cities to fight Zika virus

The U.S. Centers for Disease Control and Prevention (CDC) recently awarded $2.4 million to Chicago, Houston, New York City, Philadelphia and Los Angeles County for information-gathering systems to detect microcephaly. Microcephaly is a serious birth defect of the brain that is closely linked to... Read More »

Bavarian Nordic details advances in first half of 2016

Bavarian Nordic A/S released a summary of its progress for the first half of 2016 on Wednesday. “I am very pleased with the progress of the company this year,” Paul Chaplin, president and chief executive officer of Bavarian Nordic, said. “We have successfully built on our relationships... Read More »

NIH begins Zika virus vaccine clinical trial in humans

The National Institutes of Health (NIH) launched a clinical trial this week for an experimental vaccine to prevent Zika virus infections, an effort that comes after local transmission of the virus hit a neighborhood in Florida. “Given the Zika situation internationally and in the United... Read More »

NIAID researchers discover six Zika-related antibodies

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), released a study on Wednesday that found six Zika virus antibodies, including four that neutralize African, Asian and American strains of the virus. Dr. Michael S.... Read More »